Twist Bioscience Corp’s recent filing unveils that its Officer Cho Dennis acquired Company’s shares for reported $3684.0 on Mar 14 ’25. In the deal valued at $40.05 per share,92 shares were bought.
Then, Green Paula sold 918 shares, generating $37,558 in total proceeds. Upon selling the shares at $40.91, the SVP of Human Resources now owns 130,912 shares.
Before that, Cho Dennis sold 277 shares. Twist Bioscience Corp shares valued at $11,333 were divested by the insider at a price of $40.91 per share. As a result of the transaction, Cho Dennis now holds 111,984 shares, worth roughly $4.74 million.
Wolfe Research initiated its Twist Bioscience Corp [TWST] rating to an Outperform in a research note published on December 13, 2024; the price target was $60. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Goldman also remained covering TWST and has increased its forecast on January 17, 2024 with a “Buy” recommendation from previously “Neutral” rating. Berenberg started covering the stock on September 27, 2023. It rated TWST as “a Buy”.
Price Performance Review of TWST
On Monday, Twist Bioscience Corp [NASDAQ:TWST] saw its stock jump 5.96% to $42.34. Over the last five days, the stock has gained 15.34%. Twist Bioscience Corp shares have fallen nearly -8.89% since the year began. Nevertheless, the stocks have risen 19.13% over the past one year. While a 52-week high of $60.90 was reached on 01/24/25, a 52-week low of $27.41 was recorded on 03/04/25. SMA at 50 days reached $45.66, while 200 days put it at $46.43.
Levels Of Support And Resistance For TWST Stock
The 24-hour chart illustrates a support level at 40.19, which if violated will result in even more drops to 38.03. On the upside, there is a resistance level at 43.57. A further resistance level may holdings at 44.79. The Relative Strength Index (RSI) on the 14-day chart is 50.19, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.99, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 3.62%. Stochastics %K at 73.86% indicates the stock is a holding.
The most recent change occurred on January 05, 2023 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating along with a $33 price target.
